Last reviewed · How we verify
NCT04713332
Effectiveness of Vitamin E and Hydrogen-Rich Water on Radiation Therapy-Induced Adverse In Patients With Rectal Cancer
Phase 3 trial testing Vitamin E in Radiation-induced Injuries in Patients With Rectal Cancer in 60 participants. Status unknown.
8 March 2021
Quick facts
| Lead sponsor | University of Jordan |
|---|---|
| Phase | Phase 3 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 6 July 2019 |
| Primary completion | 8 March 2021 |
| Estimated completion | 8 May 2021 |
| Sites | 1 location across Palestinian Territories |
Drugs / interventions tested
- Vitamin E (VITAMIN E) — full drug profile →
- Hydrogen rich water
- placebo
Conditions studied
- Radiation-induced Injuries in Patients With Rectal Cancer — all drugs for Radiation-induced Injuries in Patients With Rectal Cancer →
Sponsor
University of Jordan
Who can join
18 and older, any sex, with Radiation-induced Injuries in Patients With Rectal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Controlled studies investigating the effects of vitamin E or H2 water or comparing their effectiveness on radiation therapy-induced injuries in RC patients are generally lacking. The present study hypothesis the following: (1) Pre - radiation therapy administration of vitamin E to patients with rectal carcinoma will provide radioprotection for exposed healthy tissues. (2) Consumption of H2 water by patients with rectal carcinoma undergoing RT will reduce the side effects of this modality. (3) Rectal cancer patients receiving H2 water will show better biological improvement than those receiving only vitamin E, i.e., H2 water is more effective antioxidant than vitamin E. (4) The proposed radiation countermeasures will not compromise the anti-tumor effects.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential.
Xiao YL, Gong Y, Qi YJ, Shao ZM, et al · · 2024 · cited 120× · PMID 38462638 · DOI 10.1038/s41392-024-01771-x -
Ionizing radiation: molecular mechanisms, biological effects, and therapeutic targets.
Wei W, Ren Y, Lan J, Yi J, et al · · 2026 · PMID 41507636 · DOI 10.1186/s43556-025-00358-4
Verify or expand the search:
- PubMed search for NCT04713332
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vitamin E
Trials testing the same drug.
- NCT07331103 — RESOLving INflammation Through Diet for Health (RESOLVIN) · NA · recruiting
- NCT06081257 — The Effect of "KB-120" Small Molecular Nutrient in Women With Decreased Ovarian Reserve · NA · unknown
- NCT05616442 — Ketotifen in Non-Alcoholic Fatty Liver Disease Patients · Phase 4 · completed
- NCT06211478 — Role of Vitamin E in Gaucher Disease Patients · Phase 3 · completed
- NCT04801849 — Vitamin E Dosing Study · Phase 2 · completed
Other University of Jordan trials
Trials by the same sponsor.
- NCT07370545 — Impact of Presentation Sequence on Patient Tooth Shade Selection · NA · completed
- NCT07279285 — Sweet-Tasting Solution Versus Placebo to Reduce Pain During Local Anesthetic Injection in Children · NA · not yet recruiting
- NCT07310485 — Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausa · NA · enrolling by invitation
- NCT06977009 — Influence of Occlusal Reduction on Endodontic Postoperative Pain · NA · recruiting
- NCT07212413 — Effect of Snow-plow Technique on the Postoperative Pain Following Direct Composite Restoration · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04713332 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Jordan
- Last refreshed: 17 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04713332.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing